Recent Insider Selling: NVIDIA Corporation (NASDAQ:NVDA), CBS Corporation (NYSE:CBS), Yelp Inc. (NYSE:YELP), Arena Pharmaceutical (NASDAQ:ARNA)

NVIDIA (NASDAQ:NVDA) CAO David Shannon sold 2,227 shares of the stock in a transaction that occurred on Tuesday, April 8th. The shares were sold at an average price of $18.62, for a total value of $41,466.74. Following the completion of the sale, the chief accounting officer now directly owns 240,917 shares of the company’s stock, valued at approximately $4,485,875. NVIDIA Corporation (NASDAQ:NVDA) shares after opening at $18.34 moved to $18.55 on last trade day and at the end of the day closed at $18.45. Company price to sales ratio in past twelve months was calculated as 2.49 and price to cash ratio as 2.20. NVIDIA Corporation (NASDAQ:NVDA) showed a negative weekly performance of -2.17%.

CBS Corporation (NYSE:CBS) shares advanced 0.65% in last trading session and ended the day on $59.17. CBS return on equity ratio is recorded as 19.50% and its return on assets is 7.20%. CBS Corporation (NYSE:CBS) yearly performance is 29.25%.

Yelp (NASDAQ:YELP) COO Geoffrey Donaker sold 25,000 shares of the company’s stock in a transaction dated Thursday, April 10th. The shares were sold at an average price of $69.79, for a total transaction of $1,744,750.00. Yelp Inc. (NYSE:YELP) shares moved up 1.81% in last trading session and was closed at $63.06, while trading in range of $58.81 – $63.80. Yelp Inc. (NYSE:YELP) year to date (YTD) performance is -8.54%.

Arena Pharmaceuticals (NASDAQ:ARNA) Director Tina Susan Nova sold 35,000 shares of the stock on the open market in a transaction dated Monday, April 14th. The shares were sold at an average price of $6.22, for a total value of $217,700.00. Following the sale, the director now directly owns 18,728 shares in the company, valued at approximately $116,488. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) weekly performance is -1.24%. On last trading day company shares ended up $6.35. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) distance from 50-day simple moving average (SMA50) is -3.01%. Analysts mean target price for the company is $7.83.